logo

GRCE

Grace Therapeutics·NASDAQ
--
--(--)
--
--(--)

GRCE fundamentals

Grace Therapeutics (GRCE) released its earnings on Aug 12, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.21 (YoY +12.50%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.21
+12.50%
Report date
Aug 12, 2025

Earnings

EPS
Revenue

Revenue & Expenses

Key Indicators

Grace Therapeutics (GRCE) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Grace Therapeutics (GRCE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Grace Therapeutics (GRCE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Grace Therapeutics (GRCE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Grace Therapeutics (GRCE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Grace Therapeutics (GRCE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield